Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice

Atherosclerosis

Volumn 189, Issue 2, 2006, Pages 318-327

  Arbonés Mainar, José M ^a   Navarro, María A ^a   Guzmán, Mario A ^a   Arnal, Carmen ^a   Surra, Joaquín C ^a   Acín, Sergio ^a   Carnicer, Ricardo ^a   Osada, Jesús ^a   Roche, Helen M ^b  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Apolipoprotein; Atherosclerosis; Chitotriosidase; CLA; Paraoxonase

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; APOLIPOPROTEIN E; CHITOTRIOSIDASE; CHOLESTEROL; CONJUGATED LINOLEIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; ARTICLE; ATHEROSCLEROSIS; CONJUGATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HYPERLIPIDEMIA; INFLAMMATION; ISOMER; KNOCKOUT MOUSE; LIPID METABOLISM; MACROPHAGE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE; STAINING; VASCULAR DISEASE;

ANIMALS; AORTA; APOLIPOPROTEINS E; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; DIET, ATHEROGENIC; DINOPROST; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEXOSAMINIDASES; ISOMERISM; LINOLEIC ACIDS, CONJUGATED; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS;

EID: 33744948553     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.01.015     Document Type: Article

References (65)

1. Parodi P.W. Conjugated octadecadienoic acids of milk fat. J Dairy Sci 60 (1977) 1550-1553
2. Peterson D.G., Matitashvili E.A., and Bauman D.E. Diet-induced milk fat depression in dairy cows results in increased trans-10,cis-12 CLA in milk fat and coordinate suppression of mRNA abundance for mammary enzymes involved in milk fat synthesis. J Nutr 133 (2003) 3098-3102
3. Wahle K.W.J., Heys S.D., and Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health?. Prog Lipid Res 43 (2004) 553-587
4. Parodi P.W. Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J Dairy Sci 82 (1999) 1339-1349
5. Rudel L.L. Atherosclerosis and conjugated linoleic acid. Br J Nutr 81 (1999) 177-179
6. Pariza M.W., Park Y., and Cook M.E. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med 223 (2000) 8-13
7. MacDonald H.B. Conjugated linoleic acid and disease prevention: a review of current knowledge. J Am Coll Nutr 19 (2000) 111S-118S
8. Belury M.A. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr 22 (2002) 505-531
9. Roche H.M., Noone E., Sewter C., et al. Isomer-dependent metabolic effects of conjugated linoleic acid: insights from molecular markers sterol regulatory element-binding protein-1c and LXRalpha. Diabetes 51 (2002) 2037-2044
10. Murray C.J.L., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
11. Lusis A.J., and Atherosclerosis. Nature 407 (2000) 233-241
12. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
13. Lee K., Kritchevsky D., and Pariza M. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108 (1994) 19-25
14. Kritchevsky D., Tepper S.A., Wright S., Tso P., and Czarnecki S.K. Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr 19 (2000) 472S-477S
15. Kritchevsky D., Tepper S.A., Wright S., and Czarnecki S.K. Influence of graded levels of conjugated linoleic acid (CLA) on experimental atherosclerosis in rabbits. Nutr Res 22 (2002) 1275-1279
16. Kritchevsky D., Tepper S.A., Wright S., Czarnecki S.K., Wilson T.A., and Nicolosi R.J. Conjugated linoleic acid isomer effects in atherosclerosis: growth and regression of lesions. Lipids 39 (2004) 611-616
17. Nicolosi R., Rogers E., Kritchevsky D., Scimeca J., and Huth P. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 22 (1997) 266-277
18. Wilson T.A., Nicolosi R.J., Chrysam M., and Kritchevsky D. Conjugated linoleic acid reduces early aortic atherosclerosis greater than linoleic acid in hypercholesterolemic hamsters. Nutr Res 20 (2000) 1795-1805
19. Munday J.S., Thompson K.G., and James K.A. Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br J Nutr 81 (1999) 251-255
20. Yamasaki M., Ikeda A., Hirao A., et al. Dose-dependent effect of dietary conjugated linoleic acid on the growth of rat hepatoma dRLh-84 cells in vivo. J Nutr Sci Vitaminol (Tokyo) 48 (2002) 505-511
21. Nakanishi T., Koutoku T., Kawahara S., Murai A., and Furuse M. Dietary conjugated linoleic acid reduces cerebral prostaglandin E(2) in mice. Neurosci Lett 341 (2003) 135-138
22. Belton O.A., Duffy A., Toomey S., and Fitzgerald D.J. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis. Circulation 108 (2003) 3017-3023
23. Torres-Duarte A.P., and Vanderhoek J.Y. Conjugated linoleic acid exhibits stimulatory and inhibitory effects on prostanoid production in human endothelial cells and platelets. Biochim Biophys Acta 1640 (2003) 69-76
24. Yu Y., Correll P.H., and Vanden Heuvel J.P. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR[gamma]-dependent mechanism. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids 1581 (2002) 89-99
25. Toomey S, Harhen B, Roche HM, Fitzgerald D, Belton O. Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 2005 [Epub ahead of print] 16182300.
26. Brown J.M., Boysen M.S., Chung S., et al. Conjugated linoleic acid induces human adipocyte delipidation: autocrine/paracrine regulation of MEK/ERK signaling by adipocytokines. J Biol Chem 279 (2004) 26735-26747
27. Granlund L., Juvet L.K., Pedersen J.I., and Nebb H.I. trans-10,cis-12-Conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator. J Lipid Res 44 (2003) 1441-1452
28. Osada J., Joven J., and Maeda N. The value of apolipoprotein E knockout mice for studying the effects of dietary fat and cholesterol on atherogenesis. Curr Opin Lipidol 11 (2000) 25-29
29. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., and Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14 (1994) 133-140
30. Rosenfeld M.E., Polinsky P., Virmani R., Kauser K., Rubanyi G., and Schwartz S.M. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 20 (2000) 2587-2592
31. Williams H., Johnson J.L., Carson K.G., and Jackson C.L. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 22 (2002) 788-792
32. Calara F., Silvestre M., Casanada F., Yuan N., Napoli C., and Palinski W. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol 195 (2001) 257-263
33. Meir K.S., and Leitersdorf E. Atherosclerosis in the apolipoprotein E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24 (2004) 1006-1014
34. Escola-Gil J.C., Jorba O., Julve-Gil J., Gonzalez-Sastre F., Ordonez-Llanos J., and Blanco-Vaca F. Pitfalls of direct HDL-cholesterol measurements in mouse models of hyperlipidemia and atherosclerosis. Clin Chem 45 (1999) 1567-1569
35. Acín S., Navarro M.A., Carnicer R., et al. Dietary cholesterol suppresses the ability of olive oil to delay the development of atherosclerotic lesions in apolipoprotein E knockout mice. Atherosclerosis 182 (2005) 17-28
36. Artieda M., Cenarro A., Ganan A., et al. Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 23 (2003) 1645-1652
37. Navarro M.A., Carpintero R., Acin S., et al. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation. Cytokine 31 (2005) 52-63
38. Tangirala R., Rubin E., and Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 36 (1995) 2320-2328
39. Paigen B., Morrow A., Holmes P.A., Mitchell D., and Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68 (1987) 231-240
40. Teupser D., Persky A.D., and Breslow J.L. Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arterioscler Thromb Vasc Biol 23 (2003) 1907-1913
41. Fournier T., Medjoubi-N N., and Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta Protein Struct Mol Enzymol 1482 (2000) 157-171
42. Mitchell P.L., Langille M.A., Currie D.L., and McLeod R.S. Effect of conjugated linoleic acid isomers on lipoproteins and atherosclerosis in the Syrian Golden hamster. Biochim Biophys Acta 1734 (2005) 269-276
43. Valeille K., Ferezou J., Amsler G., et al. A cis-9,trans-11-conjugated linoleic acid-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster. Am J Physiol Heart Circ Physiol 289 (2005) H652-H659
44. Terpstra A.H. Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate. J Nutr 131 (2001) 2067-2068
45. Arbonés-Mainar J.M., Navarro M.A., Acín S., et al. trans-10,cis-12- and cis-9,trans-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. J Nutr 136 (2006) 353-359
46. Yang M., and Cook M.E. Dietary CLA decreased weight loss and extended survival following the onset of kidney failure in NZB/W F1 mice. Lipids 38 (2003) 21-24
47. Park Y., Storkson J.M., Albright K.J., Liu W., and Pariza M.W. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 34 (1999) 235-241
48. Riserus U., Basu S., Jovinge S., Fredrikson G.N., Arnlov J., and Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 106 (2002) 1925-1929
49. Riserus U., Arner P., Brismar K., and Vessby B. Treatment with dietary trans-10,cis-12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25 (2002) 1516-1521
50. Tricon S., Burdge G.C., Kew S., et al. Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr 80 (2004) 614-620
51. Moloney F., Yeow T.P., Mullen A., Nolan J.J., and Roche H.M. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 80 (2004) 887-895
52. Toomey S., Roche H., Fitzgerald D., and Belton O. Regression of pre-established atherosclerosis in the apoE-/- mouse by conjugated linoleic acid. Biochem Soc Trans 31 (2003) 1075-1079
53. Davies M.J. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 82 (1990) II38-II46
54. Libby P., Schoenbeck U., Mach F., Selwyn A.P., and Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med 104 (1998) 14S-18S
55. Lafont A. Basic aspects of plaque vulnerability. Heart 89 (2003) 1262-1267
56. Yang M., and Cook M.E. Dietary conjugated linoleic acid decreased cachexia, macrophage tumor necrosis factor-alpha production, and modifies splenocyte cytokines production. Exp Biol Med (Maywood) 228 (2003) 51-58
57. Weldon S., Mitchell S., Kelleher D., Gibney M.J., and Roche H.M. Conjugated linoleic acid and atherosclerosis: no effect on molecular markers of cholesterol homeostasis in THP-1 macrophages. Atherosclerosis 174 (2004) 261-273
58. Schultz J.R., Verstuyft J.G., Gong E.L., Nichols A.V., and Rubin E.M. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 365 (1993) 762-764
59. Ansell B.J., Navab M., Hama S., et al. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation 108 (2003) 2751-2756
60. Asztalos B.F., Cupples L.A., Demissie S., et al. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 24 (2004) 2181-2187
61. Fusetti F., von Moeller H., Houston D., et al. Structure of human chitotriosidase implications for specific inhibitor design and function of mammalian chitinase-like lectins. J Biol Chem 277 (2002) 25537-25544
62. Boot R.G., van Achterberg T.A.E., van Aken B.E., et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 19 (1999) 687-694
63. Lutgens E., Faber B., Schapira K., et al. Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody. Circulation 111 (2005) 3443-3452
64. Takahashi K., Mizuarai S., Araki H., et al. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 278 (2003) 46654-46660
65. Terpstra A.H. Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature. Am J Clin Nutr 79 (2004) 352-361